Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them.

Weight-loss drug Wegovy cuts heart attack risk among obese, study says - The Washington Post

Wegovy found to reduce risk of serious heart problems, Health Smart

Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk

Semaglutide used for weight loss also helps reduce heart failure symptoms, study finds - ABC News

Study: Weight loss drug cut risk of serious heart problems

Study Finds Wegovy Drug Reduces Heart Attack, Stroke Risks by 20%

Obesity Drug Wegovy Cut Risk of Serious Heart Problems by 20%, Study Finds, The Well News

Weight loss drug Wegovy slashes risk of serious heart complications

Weight-loss drug Wegovy produces 'largest benefit ever seen' for patients with most common form of heart failure, trial finds

Study: Weight loss drug cut risk of serious heart problems

Weight-Loss Stocks (LLY, WW) Soar as Wegovy Heart Study Spur Obesity-Drug Frenzy - Bloomberg

Semaglutide helps reduce risk of heart attack, stroke in people without diabetes, study finds –

Obesity drug Wegovy cut risk of serious heart problems by 20%: Study

Weight loss drug Wegovy reduces risk of serious heart disease, new trial finds - Vox

Study published that finds obesity drug Wegovy lowers risk of serious heart problems